Clinical Trials Logo

Clinical Trial Summary

The prenylflavonoids 6-prenylnaringenin (6-PN) and 8-prenylnaringenin (8-PN) are secondary plant substances, almost exclusively found in hops (Humulus lupulus). Both compounds have known potential biological properties, but poor bioavailability due to their low oral absorption and retention. Our study followed a single dose (500 mg 6- or 8-PN), placebo controlled, randomized, double-blind, three armed crossover study design with ≥2-week washout periods. Plasma, PBMC and urine samples were collected at intervals up to 24 h after intake. Investigators investigated the safety, pharmacokinetics and impact of oral prenylflavonoids on the function of cells of the immune system.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03140397
Study type Interventional
Source University of Hohenheim
Contact
Status Completed
Phase Early Phase 1
Start date January 2016
Completion date December 31, 2017

See also
  Status Clinical Trial Phase
Completed NCT02944097 - Bioavailability of Resveratrol From Vineatrol30 Extract Incorporated Into Micelles Early Phase 1
Completed NCT03530436 - Comparison of Curcumin Bioavailability N/A
Completed NCT02944084 - Absorption and Excretion Kinetics of the Bioactive Ingredients of Rice Bran Extract Early Phase 1